Gabriel Minarik

Gabriel Minarik

Auto-generated profile, based on publicly available information

Gabriel Minarik

Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2013 in Biological Procedures Online
Verified
Journal Article
Open access
PDF file
TSTatiana Sedlackova
Tatiana Sedlackova
GRGabriela Repiska
Gabriela Repiska
Peter CelecPeter Celec
Peter Celec
TSTomas Szemes
Tomas Szemes
GMGabriel Minarik
Gabriel Minarik
Specific applications and modern technologies, like non-invasive prenatal testing, non-invasive cancer diagnostic and next generation sequencing, are currently in the focus of researchers worldwide. These have common characteristics in use of highly fragmented DNA molecules for analysis. Hence, for the performance of molecular methods, DNA concentration is a crucial parameter; we compared the influence of different levels of DNA fragmentation on the accuracy of DNA concentration measurements.

19 February 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Michal MegoMichal Mego
Michal Mego
DCDana Cholujova
Dana Cholujova
GMG. Minarik
G. Minarik
TST. Sedlackova
T. Sedlackova
PGP. Gronesova
P. Gronesova
JMJ. Mardiak
J. Mardiak
Cytokines are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play key role in tumor dissemination and are an independent survival predictor in breast cancer patients. The aim of this study was to assess correlation between CTCs and plasma cytokines in primary breast cancer (PBC) patients. This study included 147 chemotherapy naïve PBC patients. Peripheral blood mononuclear cells (PBMC) were depleted of hematopoetic cells using RossetteSep™ negative selection kit. RNA extracted from CD45-depleted PBMC was interrogated for expression of EMT (Twist1, Snail1, Slug, Zeb1) and epithelial (Ck19) gene transcripts by qRT-PCR. The concentrations of 51 plasma cytokines were measured using multiplex bead arrays. CTCs were detected in 25.2 % patients. CTCs exhibiting only epithelial markers (CTC_EP) and only EMT markers (CTC_EMT) were present evenly in 11.6 % patients, while CTCs co-expressing both markers were detected in 2.0 % patients. Patients with presence of CTC_EP in peripheral blood had significantly elevated levels of plasma IFN-α2, IL-3, MCP-3, β-NGF, SCF, SCGF-β, TNF-β and SDF-1 compared to patients without CTC_EP. CTC_EP exhibited overexpression of SDF-1 receptor and CXCR4, but not other corresponding cytokine receptor, and in multivariate analysis SDF-1 was independently associated with CTC_EP. There was an inverse correlation between CTC_EMT and plasma cytokines CTACK, β-NGF and TRAIL, while presence of either subtype of CTCs was associated with increased level of TGF-β2. Using cytokine profiling, we identified cytokines associated with CTCs subpopulations in peripheral blood of PBC. Our data suggest that CXCR4-SDF-1 axis is involved in mobilization and trafficking of epithelial CTCs.

1 December 2012 in Archives of Oral Biology
Verified
Journal Article
Closed access
BVBarbora Vlkova
Barbora Vlkova
PSPeter Stanko
Peter Stanko
GMGabriel Minárik
Gabriel Minárik
LTLubomira Tothova
Lubomira Tothova
TSTomas Szemes
Tomas Szemes
Peter CelecPeter Celec
Peter Celec

28 June 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZCZuzana Cierna
Zuzana Cierna
Michal MegoMichal Mego
Michal Mego
PJPavol Janega
Pavol Janega
MKMarian Karaba
Marian Karaba
GMGabriel Minarik
Gabriel Minarik
JMJozef Mardiak
Jozef Mardiak
Matrix metalloproteinases (MMPs) are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play role in tumor dissemination and are an independent survival predictor in breast cancer (BC) patients. The aim of this study was to assess correlation between CTCs and tumor MMP1 in BC.

15 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GMGabriel Minarik
Gabriel Minarik
GRGabriela Repiska
Gabriela Repiska
MHMichaela Hyblova
Michaela Hyblova
ENEmilia Nagyova
Emilia Nagyova
KSKatarina Soltys
Katarina Soltys
TSTomas Szemes
Tomas Szemes
The aims of this study were to test the utility of benchtop NGS platforms for NIPT for trisomy 21 using previously published z score calculation methods and to optimize the sample preparation and data analysis with use of in silico and physical size selection methods. Samples from 130 pregnant women were analyzed by whole genome sequencing on benchtop NGS systems Ion Torrent PGM and MiSeq. The targeted yield of 3 million raw reads on each platform was used for z score calculation. The impact of in silico and physical size selection on analytical performance of the test was studied. Using a z score value of 3 as the cut-off, 98.11% - 100% (104-106/106) specificity and 100% (24/24) sensitivity and 99.06% - 100% (105-106/106) specificity and 100% (24/24) sensitivity were observed for Ion Torrent PGM and MiSeq, respectively. After in silico based size selection both platforms reached 100% specificity and sensitivity. Following the physical size selection z scores of tested trisomic samples increased significantly—p = 0.0141 and p = 0.025 for Ion Torrent PGM and MiSeq, respectively. Noninvasive prenatal testing for chromosome 21 trisomy with the utilization of benchtop NGS systems led to results equivalent to previously published studies performed on high-to-ultrahigh throughput NGS systems. The in silico size selection led to higher specificity of the test. Physical size selection performed on isolated DNA led to significant increase in z scores. The observed results could represent a basis for increasing of cost effectiveness of the test and thus help with its penetration worldwide.

Verified
Journal Article
Open access
PDF file
DHDominik Hadzega
Dominik Hadzega
GMGabriel Minarik
Gabriel Minarik
MKMarian Karaba
Marian Karaba
KKKatarina Kalavska
Katarina Kalavska
JBJuraj Benca
Juraj Benca
Michal MegoMichal Mego
Michal Mego
Recent research studies are showing breast tissues as a place where various species of microorganisms can thrive and cannot be considered sterile, as previously thought. We analysed the microbial composition of primary tumour tissue and normal breast tissue and found differences between them and between multiple breast cancer phenotypes. We sequenced the transcriptome of breast tumours and normal tissues (from cancer-free women) of 23 individuals from Slovakia and used bioinformatics tools to uncover differences in the microbial composition of tissues. To analyse our RNA-seq data (rRNA depleted), we used and tested Kraken2 and Metaphlan3 tools. Kraken2 has shown higher reliability for our data. Additionally, we analysed 91 samples obtained from SRA database, originated in China and submitted by Sichuan University. In breast tissue, the most enriched group were Proteobacteria, then Firmicutes and Actinobacteria for both datasets, in Slovak samples also Bacteroides, while in Chinese samples Cyanobacteria were more frequent. We have observed changes in the microbiome between cancerous and healthy tissues and also different phenotypes of diseases, based on the presence of circulating tumour cells and few other markers.